NGeneBio Co., Ltd.
주식회사 엔젠바이오
Verification summary
- Legal name (EN / KO)
- NGeneBio Co., Ltd. (주식회사 엔젠바이오)
- Business registration no.
435-88-00238(4358800238)- Stock listing
- KOSDAQ listed · stock code
354200· DART01397903 - 12-month KONEPS contracts
1contract · KRW 601,084,740- Live NTS tax status
- Check live NTS status ↗
- verified_at
How to verify a Korean company (BRN format, live NTS status, DART & KONEPS) →
- English name (as registered with DART)
- NGeneBio Co., Ltd.
- Korean legal name
- 주식회사 엔젠바이오
- Alternate names
- 엔젠바이오
- Market
KOSDAQ- Stock Code
354200- DART Corp Code
01397903- CEO
- 이경남
- Business Registration No.
435-88-00238- Corporate Registration No.
1101115877480- Established Date
2015-10-30- Fiscal Month
12- KSIC Industry Code
739- Address (KO)
- 서울특별시 구로구 디지털로 288 303호. 304호. 305호. 306호. 307호. 제지1층 제비 127호, 제지1층 제비 1
- Homepage
- https://ngenebio.com/ ↗
English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.
2026-11-01 04:39 UTCAnnual Financial Summary (KRW)
2025
Basis CFS (Consolidated)
Currency KRW
| Account | FY2025 (Current) | FY2024 (Prior) |
|---|---|---|
| Revenue (매출액) | KRW 21,239,519,701 | KRW 5,610,966,456 |
| Operating Income (영업이익) | KRW -8,276,064,402 | KRW -12,591,956,332 |
| Net Income (당기순이익) | KRW -6,757,443,421 | KRW -14,290,145,486 |
| Total Assets (자산총계) | KRW 72,337,772,001 | KRW 32,949,992,449 |
| Total Liabilities (부채총계) | KRW 49,745,286,622 | KRW 15,241,102,378 |
| Total Equity (자본총계) | KRW 22,592,485,379 | KRW 17,708,890,071 |
2026-11-08 02:22 UTCRecent DART Filings (Last 90 Days, up to 20)
| Filed | Theme | Filing (EN) | Filer |
|---|---|---|---|
| No filings in the last 90 days. | |||
Data from Korea's Financial Supervisory Service (OpenDART). FSS does not guarantee accuracy or completeness. Figures as filed, in the currency shown (usually KRW). Not investment advice. English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.
2026-11-01 04:39 UTCPublic procurement (last 12 months)
Contracts first signed in the last 12 months.
The 12-month window is by original contract signing date: it covers contracts first signed in the period, and excludes amendments registered in the period to contracts signed earlier. Amounts are in KRW from Korea's Public Procurement Service (KONEPS). The 12-month total counts sole contracts in full and joint contracts by the supplier's share; joint contracts without a published share are counted but not summed. Multi-year contracts count only the current-period amount. Unit-price (framework) contracts are reported separately because their values are ceilings, not spend. Where KONEPS reports no total contract amount, the current-period amount is used as the total.
- Aggregation Period
2025-11-08to2026-11-07(basis:original_signed_date)- 12-Month Procurement Amount
- KRW 601,084,740
- 12-Month Contract Count
1(Joint contracts:0)- Unit-Price (Framework) Contracts (Reported Separately)
0contracts | Ceiling: KRW 0
By Procurement Category
| Category | Contracts | 12M Counted Amount (KRW) |
|---|---|---|
| Goods (물품) | 0 | KRW 0 |
| Construction (공사) | 0 | KRW 0 |
| Services (용역) | 1 | KRW 601,084,740 |
| Foreign Procurement (외자) | 0 | KRW 0 |
By Contract Type
| Contract Type | Contracts | Supplier Share / Current Amount (KRW) | Total Contract Ceiling / Multi-year Total (KRW) |
|---|---|---|---|
| Lump-sum / Standard (총액·일반) | 1 | KRW 601,084,740 | KRW 601,084,740 |
| Multi-year / Continuing (장기·계속비) | 0 | KRW 0 | KRW 0 |
| Unit-price / Framework Ceiling (단가·제3자단가 — excluded from 12M total) | 0 | KRW 0 | KRW 0 |
| Unclassified / Zero-amount (기타) | 0 | KRW 0 | KRW 0 |
Top 5 Government Buyers
| Buyer (Korean Legal Name) | Agency Code | Contracts | 12M Amount (KRW) |
|---|---|---|---|
| 메디사피엔스 주식회사 | Z061600 | 1 | KRW 601,084,740 |
Recent Contracts (up to 1)
| Signed Date | Contract No. (KONEPS) | Contract Title (KO) | Category / Type | Buyer (KO) | Contract Amount (KRW) | Participation |
|---|---|---|---|---|---|---|
| 2026-10-12 | R26TA02305150 ↗ |
AX-Sprint 300 사업 DNA서열분석기 (차세대염기서열분석) 장비 임차 계약 | services / lump_sum |
메디사피엔스 주식회사 | KRW 601,084,740 | Sole (100%) |